Navigation Links
Micromet Announces Public Offering of Common Stock
Date:7/29/2009

BETHESDA, Md., July 29 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole book running manager, with RBC Capital Markets as co-manager in this offering. The offering is being made pursuant to a shelf registration statement filed with the Securities and Exchange Commission on June 19, 2009, which became effective on July 2, 2009. A prospectus supplement relating to the offering will be filed with the Securities and Exchange Commission.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. When available, copies of the prospectus supplement relating to this offering may be obtained by contacting Piper Jaffray & Co. by mail at 800 Nicollet Mall, Suite 800, Minneapolis, MN 55402, or by telephone at (800) 747-3924.

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE(R) antibody platform, as well as conventional monoclonal antibodies. BiTE antibodies represent a new class of antibodies that activate the T cells of a patient's immune system to eliminate cancer cells. Five of Micromet's antibodies
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Host Conference Call and Webcast to Report Second Quarter 2009 Financial Results on August 6, 2009
2. Micromet Added to Russell 3000 Index
3. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
4. Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
5. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
6. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
7. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
8. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
9. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
10. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
11. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire-FirstCall/--Sigma-AldrichCorporation(Nasdaq:...uesday,December1stat1:45PMGMTinLondon,7:45AMUS/CST...ertheInternetavailableat http://inve s tor.sig ...contoaccessthisfile. ,, AboutSigma-Aldrich: ...ycompany.Itschemicalandbiochemicalproductsandkitsa...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasdaq: NG...ndcommercializingnovelpainmanagementtherapies,anno...utiveOfficer,isscheduledtopresentatthe21stAnnualPi...,2009atTheNewYorkPalaceHotelinNewYork,NewYork. ,...icer,willbeavailabletorespondtoquestionsduringthep...
(Date:11/24/2009)...nthasbeenmetforpatientswithadvanced-stage,orrecurr...ewswire-FirstCall/-AEternaZentarisInc.(NASDAQ: AEZ...companyfocusedonendocrinetherapyandoncology,todaya...stargetedcytotoxicpeptideconjugate,AEZS-108(former...rialcancer.Inapersonalizedhealthcareapproach,thest...
(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--GenomicHealth,Inc.(Nas...lth,sExecutiveChairman,willpresentatthe21stAnnualP...day,December1,2009at10:00a.m.ET. ,, Toaccessthe...n,visittheInvestorRelationssectionofGenomicHealth,...seconnecttothewebsiteatleast15minutespriortothebeg...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
..., April 7 /PRNewswire-Asia-FirstCall/ -- China Sky...e Company") (Nasdaq: CSKI ), a,leading fully int...counter drugs in the People,s Republic of China ("...ion filed with the Securities and,Exchange Commiss..., 2009, is,related to a technical non-cash account...
...Eindhoven University of Technology (TU/e) have dev...l reactions. For the first time they used mechanic...e most fundamental concepts in chemistry. This all...anical force. This discovery paves the way to deve...nder the influence of mechanical tension. The resu...
...eversed hemophilia in mice , , GAITHERSBURG, Md.,...e publication of a new research article, " Trans -...for Production of Therapeutic Proteins In Vivo," ...scribes a novel RNA therapy technique in which an ...ne "hijacks" the albumin, causing it to produce th...
Other Biology Technology:China Sky One Medical, Inc. Provides Update on Filing Form 10-K 2China Sky One Medical, Inc. Provides Update on Filing Form 10-K 3A molecular ripcord for chemical reactions 2VIRxSYS Publishes New Study on RNA Therapy 2
(Date:11/23/2009)..., 2009 Applied mathematicians dissected the morph... characteristic long leaf with a saddle-like arc m...es. The simple cause of the lily,s fan-like shapee...fferential growthwas revealed by using an equally ...yi Liang, a postdoctoral student at Harvard,s Scho...
(Date:11/23/2009)...suggests that a common oral bacterium may exacerba...ols et al, "Unique Lipids from a Common Human Bact...e of Enhancing Autoimmunity," appears in the Decem...gy . , Multiple sclerosis (MS), a disease where ...d, affects nearly 1 in 700 people in the United St...
(Date:11/23/2009)... A USDOE and USDA study concluded that 50 million ...d pasture could be converted from current uses to ...hgrass, from which biomass could be harvested for ...oduction of a perennial grass monoculture from whi...nnually is expected to require nitrogen fertilizer...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Factors from common human bacteria may trigger multiple sclerosis 2Switchgrass produces biomass efficiently 2AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 1AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 2AEterna Zentaris Receives US 2410 Million from Institutional Investors 12773 3MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 1MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 2MarketArt to Provide APCO With Rapid Response at World 26apos 3Bs Largest Public Safety Communications Event 49962 3Michigan Health 26 Hospital Association Elects 2009 Officers and Board Members 49957 1Michigan Health 26 Hospital Association Elects 2009 Officers and Board Members 49957 2
...ide in designated Special Areas of Conservation th...rnwall, might be at risk from pile driving. The fr...e with their ability to communicate, find food and... their behaviour, health and their ability to bree... might be particularly vulnerable , Recently more...
...nth,s issue of Angiology shows that supplementatio...en-all) improves blood flow to the muscles which s...of 113 participants demonstrated that Pycnogenol s...thletes and healthy, normal individuals. , "With ...a profound breakthrough and extremely significant ...
...e found that a method they developed to screen bod...eir genetic blueprint is twice as accurate at spot...ith a microscope. , The screen, developed by Sar... separates cells from fluid, then sifts through th...sociated with cancer. , Reporting in the June 1 ...
Other Biology News:South Pacific plant may be missing link in evolution of flowering plants 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 2Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics 3Gene screen for breast cancer better than pathologist's 'eye' 2
Rabbit Anti-Phospho RNA Polymerase II (S5) Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Anti-Acetylcholinesterase Monoclonal Antibody, Unconjugated, Clone AE-2 from CHEMICON
Power Supply for i-MyRun from Cosmo Bio Co., Ltd.
...oftware for JASCO HPLC systems. , Integrated In...te can be configured with a vast number of contro...ovides a completely integrated system to control i...nd record all instrument settings with each run. ,...
Biology Products: